Cargando…

The APC/C Ubiquitin Ligase: From Cell Biology to Tumorigenesis

The ubiquitin proteasome system (UPS) is required for normal cell proliferation, vertebrate development, and cancer cell transformation. The UPS consists of multiple proteins that work in concert to target a protein for degradation via the 26S proteasome. Chains of an 8.5-kDa protein called ubiquiti...

Descripción completa

Detalles Bibliográficos
Autores principales: Penas, Clara, Ramachandran, Vimal, Ayad, Nagi George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Research Foundation 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356048/
https://www.ncbi.nlm.nih.gov/pubmed/22655255
http://dx.doi.org/10.3389/fonc.2011.00060
_version_ 1782233488117727232
author Penas, Clara
Ramachandran, Vimal
Ayad, Nagi George
author_facet Penas, Clara
Ramachandran, Vimal
Ayad, Nagi George
author_sort Penas, Clara
collection PubMed
description The ubiquitin proteasome system (UPS) is required for normal cell proliferation, vertebrate development, and cancer cell transformation. The UPS consists of multiple proteins that work in concert to target a protein for degradation via the 26S proteasome. Chains of an 8.5-kDa protein called ubiquitin are attached to substrates, thus allowing recognition by the 26S proteasome. Enzymes called ubiquitin ligases or E3s mediate specific attachment to substrates. Although there are over 600 different ubiquitin ligases, the Skp1–Cullin–F-box (SCF) complexes and the anaphase promoting complex/cyclosome (APC/C) are the most studied. SCF involvement in cancer has been known for some time while APC/C’s cancer role has recently emerged. In this review we will discuss the importance of APC/C to normal cell proliferation and development, underscoring its possible contribution to transformation. We will also examine the hypothesis that modulating a specific interaction of the APC/C may be therapeutically attractive in specific cancer subtypes. Finally, given that the APC/C pathway is relatively new as a cancer target, therapeutic interventions affecting APC/C activity may be beneficial in cancers that are resistant to classical chemotherapy.
format Online
Article
Text
id pubmed-3356048
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Frontiers Research Foundation
record_format MEDLINE/PubMed
spelling pubmed-33560482012-05-31 The APC/C Ubiquitin Ligase: From Cell Biology to Tumorigenesis Penas, Clara Ramachandran, Vimal Ayad, Nagi George Front Oncol Oncology The ubiquitin proteasome system (UPS) is required for normal cell proliferation, vertebrate development, and cancer cell transformation. The UPS consists of multiple proteins that work in concert to target a protein for degradation via the 26S proteasome. Chains of an 8.5-kDa protein called ubiquitin are attached to substrates, thus allowing recognition by the 26S proteasome. Enzymes called ubiquitin ligases or E3s mediate specific attachment to substrates. Although there are over 600 different ubiquitin ligases, the Skp1–Cullin–F-box (SCF) complexes and the anaphase promoting complex/cyclosome (APC/C) are the most studied. SCF involvement in cancer has been known for some time while APC/C’s cancer role has recently emerged. In this review we will discuss the importance of APC/C to normal cell proliferation and development, underscoring its possible contribution to transformation. We will also examine the hypothesis that modulating a specific interaction of the APC/C may be therapeutically attractive in specific cancer subtypes. Finally, given that the APC/C pathway is relatively new as a cancer target, therapeutic interventions affecting APC/C activity may be beneficial in cancers that are resistant to classical chemotherapy. Frontiers Research Foundation 2012-01-09 /pmc/articles/PMC3356048/ /pubmed/22655255 http://dx.doi.org/10.3389/fonc.2011.00060 Text en Copyright © 2012 Penas, Ramachandran and Ayad. http://www.frontiersin.org/licenseagreement This is an open-access article distributed under the terms of the Creative Commons Attribution Non Commercial License, which permits non-commercial use, distribution, and reproduction in other forums, provided the original authors and source are credited.
spellingShingle Oncology
Penas, Clara
Ramachandran, Vimal
Ayad, Nagi George
The APC/C Ubiquitin Ligase: From Cell Biology to Tumorigenesis
title The APC/C Ubiquitin Ligase: From Cell Biology to Tumorigenesis
title_full The APC/C Ubiquitin Ligase: From Cell Biology to Tumorigenesis
title_fullStr The APC/C Ubiquitin Ligase: From Cell Biology to Tumorigenesis
title_full_unstemmed The APC/C Ubiquitin Ligase: From Cell Biology to Tumorigenesis
title_short The APC/C Ubiquitin Ligase: From Cell Biology to Tumorigenesis
title_sort apc/c ubiquitin ligase: from cell biology to tumorigenesis
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356048/
https://www.ncbi.nlm.nih.gov/pubmed/22655255
http://dx.doi.org/10.3389/fonc.2011.00060
work_keys_str_mv AT penasclara theapccubiquitinligasefromcellbiologytotumorigenesis
AT ramachandranvimal theapccubiquitinligasefromcellbiologytotumorigenesis
AT ayadnagigeorge theapccubiquitinligasefromcellbiologytotumorigenesis
AT penasclara apccubiquitinligasefromcellbiologytotumorigenesis
AT ramachandranvimal apccubiquitinligasefromcellbiologytotumorigenesis
AT ayadnagigeorge apccubiquitinligasefromcellbiologytotumorigenesis